Chemotherapy-Induced Ca2 Release Stimulates Breast Cancer Stem Cell Enrichment (Q50994157)

26 March 2018

title

Chemotherapy-Induced Ca2 Release Stimulates Breast Cancer Stem Cell Enrichment (English)

1 reference

26 March 2018

1 reference

neoplastic stem cells

1 reference

8

Gregg L Semenza

1 reference

26 March 2018

Haiquan Lu

1

1 reference

26 March 2018

Ivan Chen

2

1 reference

26 March 2018

Larissa A Shimoda

3

1 reference

26 March 2018

Youngrok Park

4

1 reference

26 March 2018

Chuanzhao Zhang

5

1 reference

26 March 2018

Linh Tran

6

1 reference

26 March 2018

Huimin Zhang

7

1 reference

26 March 2018

publication date

1 February 2017

1 reference

26 March 2018

published in

Cell Reports

1 reference

26 March 2018

volume

18

1 reference

26 March 2018

issue

8

1 reference

26 March 2018

page(s)

1946-1957

1 reference

26 March 2018

PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis

cites work

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Identification, characterization, and crystal structure of the Omega class glutathione transferases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Regulation of JNK signaling by GSTp

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Dantrolene inhibition of ryanodine receptor Ca2 release channels. Molecular mechanism and isoform selectivity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Targeting HIF-1 for cancer therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Genes that mediate breast cancer metastasis to the brain

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Tumour stem cells and drug resistance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Ryanodine receptor calcium channels and their partners as drug targets.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Polymorphism of glutathione S-transferase omega gene and risk of cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Association Between Glutathione S-Transferase M1, P1, and T1 Genetic Polymorphisms and Development of Breast Cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Metastatic stem cells: sources, niches, and vital pathways

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

The UCSC Cancer Genomics Browser: update 2013.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

The JAK2/STAT3 signaling pathway is required for growth of CD44 CD24– stem cell–like breast cancer cells in human tumors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Progress in adjuvant chemotherapy for breast cancer: an overview

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Calcium and cancer: targeting Ca2 transport

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Stat3 activation by Src induces specific gene regulation and is required for cell transformation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Regulation of the cardiac muscle ryanodine receptor by glutathione transferases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Cancer statistics, 2016

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Structural determinants of 4-chloro-m-cresol required for activation of ryanodine receptor type 1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Targeting Pyk2 for therapeutic intervention

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

The role of glutathione-S-transferase in anti-cancer drug resistance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

The paradox of response and survival in cancer therapeutics

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Structure, function and disease relevance of Omega-class glutathione transferases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

The pharmacology of intracellular Ca(2 )-release channels

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Sox2 expression in breast tumours and activation in breast cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Mechanisms of chemoresistance in cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Structure of the Inhibitor W7 Bound to the Regulatory Domain of Cardiac Troponin C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Glutathione S-conjugates as prodrugs to target drug-resistant tumors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELREP.2017.02.001

Identifiers

DOI

10.1016/J.CELREP.2017.02.001

1 reference

26 March 2018

1 reference

26 March 2018